Polyherbal Chocolate Supplementation: A Novel Adjuvant Therapy For Polycystic Ovary Syndrome (PCOS)

The study explores the development of a polyherbal chocolate formulation as a novel adjuvant therapy for managing polycystic ovary syndrome (PCOS). This formulation aims to leverage the benefits of a Chocolate Drug Delivery System, which can bypass pre-systemic elimination and first-pass metabolism, while also protecting active ingredients from degradation. The research assessed various factors such as organoleptic properties, phytochemical screening, and physical stability to ensure the formulation's consistency and effectiveness. Among the formulations tested, F2 demonstrated excellent organoleptic properties and stability, suggesting its potential for further in vivo studies using animal models.